Financial Performance - NeueHealth's Q1 2025 revenue reached $215.8 million, aligning with expectations[11] - The company achieved an Adjusted EBITDA of $13.5 million in Q1 2025, marking the fifth consecutive quarter of profitability[11] - GAAP Net Loss for Q1 2025 was ($10.8) million, compared to a GAAP Net Loss of ($4.2) million for Q1 2024[11] - The GAAP Operating Cost Ratio for Q1 2025 was 22.6%, a decrease from 27.2% in Q1 2024[11] - The Adjusted Operating Cost Ratio improved to 19.3% in Q1 2025 from 16.7% in Q1 2024[18] Balance Sheet Highlights - As of March 31, 2025, NeueHealth had $239.4 million in total cash and investments, including $94.3 million in regulated entities[14] - Non-regulated cash and short-term investments totaled $145.1 million at the end of Q1 2025, which includes $31.8 million of restricted cash and investments[14] Business Overview - NeueHealth focuses on value-driven care delivery and provider enablement, partnering with health plans, government programs, and medical groups[6] - The company aims to provide high-quality, affordable care to consumers across the ACA Marketplace, Medicare, and Medicaid[4]